| | | | | | | |
 | GILEAD SCIENCES, INC. | 0.90% | 2.36% | -12.08% | -7.14% | -4.03% | 80 075 |
| REGENERON PHARMACEUTICALS, INC. | 0.61% | 2.42% | 4.69% | 30.47% | 113.31% | 71 235 |
| VERTEX PHARMACEUTICALS | 1.23% | 4.81% | 17.76% | 21.16% | 52.90% | 66 136 |
 | WUXI APPTEC CO., LTD. | 2.72% | -0.29% | -16.92% | -27.65% | 185.65% | 42 735 |
| BIONTECH SE | -2.90% | 2.62% | -36.77% | -16.70% | --.--% | 39 612 |
 | GENMAB A/S | 2.02% | 7.03% | -17.26% | -8.92% | 81.56% | 20 205 |
 | ARGENX SE | 2.11% | 2.45% | -3.17% | 38.71% | 158.73% | 17 597 |
| BEIGENE, LTD. | 4.29% | 3.35% | -49.32% | -60.49% | 5.12% | 14 168 |
| NEUROCRINE BIOSCIENCES, INC. | 0.95% | 2.45% | 1.19% | -10.20% | 9.76% | 8 237 |
| LEGEND BIOTECH CORPORATION | 2.63% | 8.26% | -8.58% | 6.93% | --.--% | 6 572 |
| SAREPTA THERAPEUTICS, INC. | 2.76% | 7.82% | -21.01% | -10.62% | -41.31% | 6 224 |
| HALOZYME THERAPEUTICS, INC. | 1.09% | 12.30% | 10.22% | 5.00% | 183.92% | 6 106 |
| EXELIXIS, INC. | 1.83% | -11.55% | -2.84% | -27.39% | -13.07% | 5 696 |
| INTRA-CELLULAR THERAPIES, INC. | 0.26% | -2.06% | 10.58% | 45.83% | 353.96% | 5 459 |
 | BIOCON LIMITED | 5.43% | 4.25% | -6.76% | -11.11% | 31.06% | 5 197 |
| | | | | | | |
| | Durchschnitt | 1.73% | 3.08% | -8.69% | -2.14% | 85.97% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 1.08% | 2.90% | -7.21% | 1.93% | 76.38% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
